A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain

Medical Care

Volumn 54, Issue 5, 2016, Pages 435-441

  Bohnert, Amy S B ^a,b   Logan, Joseph E ^c   Ganoczy, Dara ^a,b   Dowell, Deborah ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA CENTER FOR CLINICAL MANAGEMENT RESEARCH   (United States)

^c NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

Author keywords

Opioid analgesics; Pain; Patient safety

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CHRONIC PAIN; CONTROLLED STUDY; DRUG INTOXICATION; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLING; AGED; DOSE RESPONSE; DRUG OVERDOSE; GOVERNMENT; MORTALITY; RISK FACTOR; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; CHRONIC PAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG OVERDOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84955587831     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000505     Document Type: Article

References (42)

1. Paulozzi LJ, Weisler RH, Patkar AA A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry. 2011; 72: 589-592.
2. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300: 2613-2620.
3. Okie S A flood of opioids, a rising tide of deaths. N Engl J Med. 2010; 363: 1981-1985.
4. Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. JAMA. 2015; 314: 1453-1454.
5. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315-1321.
6. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010; 152: 85-92.
7. Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171: 686-691.
8. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-Term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015; 162: 276-286.
9. Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014; 160: 38-47.
10. Ohio Governors' Cabinet Opiate Action Team. Guidelines for prescribing opioids for the treatment of chronic, non-Terminal pain. 2013. Available at: http: //www.opioidprescribing.ohio.gov/OOAT-RX-Guidelines. html. Accessed January. 12, 2016.
11. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2-guidance. Pain Physician. 2012; 15: S67-S116.
12. Paone D, Dowell D, Heller D. Preventing misuse of prescription opioid drugs. City Health Inf. 2011; 30: 23-30.
13. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD Clinical Practice Guideline: Management of Opioid Therapy for Chronic Pain. Washington, DC: Department of Veterans Affairs & Department of Defense; 2010.
14. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.
15. Furlan AD, Reardon R, Weppler C, et al. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ. 2010; 182: 923-930.
16. Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015; 350: g6380.
17. Arizona Department of Health Services. Arizona opioid prescribing guidelines. 2014. Available at: http: //azdhs.gov/audiences/clinicians/.index.php#guidelines-recommendations-home
18. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
19. World Health Organization. The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Geneva: World Health Organization; 2008.
20. Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014; 30: 605-612.
21. Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or overdose among veterans health administration patients. Pain Med. 2014; 15: 1911-1129.
22. Nelson LS, Juurlink DN. Tramadol and hypoglycemia: one more thing to worry about. JAMA Intern Med. 2015; 175: 194-195.
23. Goodman F, Gordon A, Kivlahan D, et al. Critieria for use of Buprenorphine/Naloxone and Buprenorphine Sublingual Tablets. In: VHA Pharmacy Benefits Management; 2007. Available at: .
24. Centers for Disease Control and Prevention. National Death Index. Atlanta: Centers for Disease Control and Prevention; 2010.
25. Cowper DC, Kubal JD, Maynard C, et al A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002; 12: 462-468.
26. McCarthy JF, Valenstein M, Kim HM, et al. Suicide mortality among patients receiving care in the veterans health administration health system. Am J Epidemiol. 2009; 169: 1033-1038.
27. Sohn MW, Arnold N, Maynard C, et al. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006; 4: 2.
28. Darke S. Opioid overdose and the power of old myths: what we thought we knew, what we do know and why it matters. Drug Alcohol Rev. 2014; 33: 109-114.
29. Darke S, Zador D. Fatal heroin 'overdose': a review. Addiction. 1996; 91: 1765-1772..pdf.pdf
30. National Center for Injury Prevention and Control. CDC Compilation of Opioid Analgesic Formulations With Morphine Milligram Equivalent Conversion Factors, 2014 Version. Atlanta: Center for Disease Control and Prevention; 2014. Available at: http: //www.pdmpassist.org/pdf/.BJA-performance-measure-aid-MME
31. Valenstein M, Taylor KK, Austin K, et al. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry. 2004; 161: 654-661.
32. Bohnert AS, Ilgen MA, Ignacio RV, et al. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry. 2012; 169: 64-70.
33. Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and drug overdose deaths among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015; 350: h2698. DOI: 10.1136/.bmj.h2698.
34. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139.
35. Edelman EJ, Gordon K, BeckerWC, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med. 2013; 28: 82-90.
36. Pepe MS, Fan J, Seymour CW. Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates. Acad Radiol. 2013; 20: 863-873.
37. Parikh R, Parikh S, Arun E, et al. Likelihood ratios: clinical application in day-To-day practice. Indian J Ophthalmol. 2009; 57: 217-221.
38. Franklin GM, Mai J, Turner J, et al. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012; 55: 325-331.
39. Paone D, Tuazon E, Kattan J, et al. Decrease in rate of opioid analgesic overdose deaths-Staten Island, New York City, 2011-2013. Morb Mortal Wkly Rep. 2015; 64: 491-494.
40. Bosco JL, Silliman RA, Thwin SS, et al A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010; 63: 64-74.
41. Bohnert AS, McCarthy JF, Ignacio RV, et al. Misclassification of suicide deaths: examining the psychiatric history of overdose decedents. Inj Prev. 2013; 19: 326-330.
42. Liang Y, Turner BJ. Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose?. J Pain. 2015; 16: 318-325.